December 10, 2019   The Magnificent 7: How many glaucoma medications are too many? Finding the sweet spot surrounding the number of anti-glaucoma medications translates to a balancing act with a focus on individual patient needs. Learn more ADVERTISEMENT Casting a net to diagnose, treat cancerous lesions Ultra-low-dose radiation therapy shows promise in treatment of low-grade lymphoma of the orbit and ocular surface. Find out more Anti-VEGF treatment targeted as potential nAMD treatment Research finds a reduction in refractory intraretinal and subretinal fluid along with improvement in visual acuity after receipt of five biweekly doses. Read more ADVERTISEMENT ADVERTISEMENT ADVERTISEMENT Anterior segment case studies by the up-and-coming "Intracameral tissue plasminogen activator to mitigate anterior chamber fibrin reaction in pediatric DMEK," "An Atypical Source of Pseudomonas Scleritis," and "UGH: Break an Arm to Save an Eye" – this year's top three winning entries in the Ophthalmology Times® Resident Writer's Award Program! Click to read them now.   RELATED ARTICLES   More stable surgery may help better predict effective IOL position Microscopy study suggests stem cell success in keratoconus Presbyopia-correcting IOLs: Expanding, improving last frontier AMD risk phenotypes targeted in direct-to-consumer genetic database Everything you thought you knew about astigmatism and dry eye is wrong AI model predicts future DR progression in individual patients Gene therapy offering hope for retinal, corneal patients   JOB OPPORTUNITIES   VT - University of Vermont